Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancoast Syndrome × Nivolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 220 Carcinoma, Non-Small-Cell Lung 182 Carcinoma, Renal Cell 121 Neoplasm Metastasis 86 Neoplasms 78 Squamous Cell Carcinoma of Head and Neck 68 Carcinoma, Hepatocellular 68 Colorectal Neoplasms 65 Lung Neoplasms 60 Stomach Neoplasms 46 Pancreatic Neoplasms 45 Urinary Bladder Neoplasms 36 Carcinoma, Transitional Cell 36 Breast Neoplasms 35 Hodgkin Disease 33 Head and Neck Neoplasms 33 Ovarian Neoplasms 32 Triple Negative Breast Neoplasms 29 Small Cell Lung Carcinoma 28 Sarcoma 27 Brain Neoplasms 27 Prostatic Neoplasms 26 Glioblastoma 26 Kidney Neoplasms 25 Recurrence 24 Multiple Myeloma 20 Uveal Melanoma 19 Skin Neoplasms 19 Esophageal Neoplasms 19 Uterine Cervical Neoplasms 18

Interventions

Cisplatin 2 durvalumab 1 belinostat 1 Vindesine 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Mitomycin 1 Fluorouracil 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05684276 2025-04-10

DUMAS

Fundación GECP

Phase 2 Recruiting

Pancoast Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡